We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16.7M
2
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$12.1M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$10M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$9.45M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$5.09M

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFC
2526
Ellington Financial
EFC
$1.68B
$2K ﹤0.01%
147
+11
+8% +$150
KRMN
2527
Karman Holdings
KRMN
$6.7B
$1.98K ﹤0.01%
+27
New +$1.96K
ADT icon
2528
ADT
ADT
$5.24B
$1.96K ﹤0.01%
243
-409
-63% -$3.4K
HIPO icon
2529
Hippo Holdings
HIPO
$759M
$1.96K ﹤0.01%
65
– –
FRPH icon
2530
FRP Holdings
FRPH
$451M
$1.89K ﹤0.01%
83
+32
+63% +$756
AGNC icon
2531
AGNC Investment
AGNC
$12.4B
$1.89K ﹤0.01%
176
– –
ETD icon
2532
Ethan Allen Interiors
ETD
$592M
$1.87K ﹤0.01%
82
-109
-57% -$2.72K
CPRX
2533
DELISTED
Catalyst Pharmaceutical
CPRX
$1.87K ﹤0.01%
80
– –
SHOE
2534
Shoe Station Group
SHOE
$410M
$1.86K ﹤0.01%
110
– –
PLAB icon
2535
Photronics
PLAB
$1.76B
$1.86K ﹤0.01%
58
– –
IIPR icon
2536
Innovative Industrial Properties
IIPR
$1.78B
$1.85K ﹤0.01%
39
– –
EYPT icon
2537
EyePoint Inc
EYPT
$1.04B
$1.83K ﹤0.01%
100
– –
HAFC icon
2538
Hanmi Financial
HAFC
$942M
$1.76K ﹤0.01%
65
– –
TRTX
2539
TPG RE Finance Trust
TRTX
$662M
$1.75K ﹤0.01%
203
– –
RAPP
2540
Rapport Therapeutics
RAPP
$2.01B
$1.73K ﹤0.01%
57
– –
WSFS icon
2541
WSFS Financial
WSFS
$4.14B
$1.71K ﹤0.01%
31
– –
AROW icon
2542
Arrow Financial
AROW
$664M
$1.7K ﹤0.01%
54
-132
-71% -$3.9K
SKY icon
2543
Champion Homes
SKY
$4.52B
$1.69K ﹤0.01%
20
-114
-85% -$8.98K
TMCI icon
2544
Treace Medical Concepts
TMCI
$265M
$1.69K ﹤0.01%
688
-96
-12% -$417
VAC icon
2545
Marriott Vacations Worldwide
VAC
$3.4B
$1.67K ﹤0.01%
29
-114
-80% -$6.74K
PKST
2546
DELISTED
Peakstone Realty Trust
PKST
$1.64K ﹤0.01%
114
– –
OSPN icon
2547
OneSpan
OSPN
$562M
$1.63K ﹤0.01%
127
-82
-39% -$1.11K
BTDR icon
2548
Bitdeer Technologies
BTDR
$2.76B
$1.6K ﹤0.01%
+143
New +$2.3K
LIF
2549
Life360
LIF
$4.36B
$1.6K ﹤0.01%
25
– –
HAE icon
2550
Haemonetics
HAE
$3.63B
$1.6K ﹤0.01%
20
-1,535
-99% -$103K
100 101
102
103 104

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.